Issue

Vol. 35 No. 11 (2023): Vol 35 Issue 11, 2023

Copyright (c) 2023 RITU JAIN, RITESH TIWARI, O.P. AGRAWAL, AJAY KUMAR SHUKLA

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Bioinspired Folic Acid-ADH-PLGA Polymeric Nanoparticles Loaded with Mangiferin and Piperine: A Promising Strategy for Targeted Delivery in Multidrug-Resistant Lung Cancer Cells

https://doi.org/10.14233/ajchem.2023.28268
RITU JAIN
1Department of Pharmaceutical Science, Madhyanchal Professional University, Bhopal-462044, India
RITESH TIWARI
Department of Pharmaceutical Science, Madhyanchal Professional University, Bhopal-462044, India
O.P. AGRAWAL
Department of Pharmaceutical Science, Madhyanchal Professional University, Bhopal-462044, India
AJAY KUMAR SHUKLA
Department of Pharmaceutical Science, Institute of Pharmacy, Dr. Rammanohar Lohia Avadh University, Ayodhya-224001, India
https://orcid.org/0000-0001-5689-3467

Corresponding Author(s) : AJAY KUMAR SHUKLA

ashukla1007@gmail.com

Asian Journal of Chemistry, Vol. 35 No. 11 (2023): Vol 35 Issue 11, 2023

Abstract

The current study aims to develop mangiferin and piperine dual drug-loaded folic acid-ADH-PLGA polymeric nanoparticles with bioinspired folic acid modifications which were effective carriers for site-specific delivery in multidrug-resistant lung cancer cells. Mangiferin and piperine, two pharmacological agents, were encapsulated within intelligent nanoparticles. These nanoparticles were fabricated utilizing folic acid, poly(lactic-co-glycolic acid) (PLGA), adipic dihydrazide (ADH) and pluronic F-68 as constituent materials. The successful fabrication of these intelligent polymeric nanoparticles was confirmed through comprehensive characterization employing various analytical techniques, including differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR) and atomic force microscopy (AFM). The efficacy of the intelligent polymeric nanoparticles against cancer cells was assessed through the evaluation of several parameters and their effectiveness was established utilizing the MTT assay. Furthermore, a hemolytic toxicity test was performed to ascertain whether the nanoparticles exerted any toxic effects on red blood cells. Mangiferin and piperine loaded FAP-M and FAP-P nanoparticles revealed a remarkable potential for inducing cell death. The findings from in vitro drug release assessments, hemolytic toxicity evaluations, bio-distribution analyses, MTT assays and apoptosis assessments exhibited substantial cell cycle phase arrest akin to the standard control. The comprehensive investigation and findings of the internalization process revealed the enhanced anticancer efficacy of mangiferin and piperine encapsulated in fibroblast activation protein-modified (FAP-M) and FAP-P nanoparticles as well as their biodistribution profile.

Keywords

Mangiferin Piperine Folic acid poly(lactic-co-glycolic acid) Aadipic dihydrazide Polymeric nanoparticles
JAIN, R., TIWARI, R., AGRAWAL, O., & SHUKLA, A. K. (2023). Bioinspired Folic Acid-ADH-PLGA Polymeric Nanoparticles Loaded with Mangiferin and Piperine: A Promising Strategy for Targeted Delivery in Multidrug-Resistant Lung Cancer Cells. Asian Journal of Chemistry, 35(11), 2640–2650. https://doi.org/10.14233/ajchem.2023.28268
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. L.A. Nagahara, J.S. Lee, L.K. Molnar, N.J. Panaro, D. Farrell, K. Ptak, J. Alper and P. Grodzinski, Cancer Res., 70, 4265 (2010); https://doi.org/10.1158/0008-5472.CAN-09-3716
  2. R. Misra, S. Acharya and S.K. Sahoo, Drug Discov. Today, 15, 842 (2010); https://doi.org/10.1016/j.drudis.2010.08.006
  3. S.C. Kamran and A.V. D’Amico, Hematol. Oncol. Clin. North Am., 34, 45 (2020); https://doi.org/10.1016/j.hoc.2019.08.017
  4. J. Liu, Y. Zheng and N. Xu, Medicine, 98, 14328 (2019); https://doi.org/10.1097/MD.0000000000014328
  5. N. Muhamad, T. Plengsuriyakarn and K. Na-Bangchang, Int. J. Nanomedicine, 13, 3921 (2018); https://doi.org/10.2147/IJN.S165210
  6. S. Parveen and S.K. Sahoo, J. Drug Target., 16, 108 (2008); https://doi.org/10.1080/10611860701794353
  7. X. Wang, L. Yang, Z.G. Chen and D.M. Shin, CA Cancer J. Clin., 58, 97 (2008); https://doi.org/10.3322/CA.2007.0003
  8. H. Maeda, J. Wu, T. Sawa, Y. Matsumura and K. Hori, J. Control. Release, 65, 271 (2000); https://doi.org/10.1016/S0168-3659(99)00248-5
  9. G. Kaul and M. Amiji, Pharm. Res., 19, 1061 (2002); https://doi.org/10.1023/A:1016486910719
  10. C.E. Ashley, E.C. Carnes, G.K. Phillips, D. Padilla, P.N. Durfee, P.A. Brown, T.N. Hanna, J. Liu, B. Phillips, M.B. Carter, N.J. Carroll, X. Jiang, D.R. Dunphy, C.L. Willman, D.N. Petsev, D.G. Evans, A.N. Parikh, B. Chackerian, W. Wharton, D.S. Peabody and C.J. Brinker, Nat. Mater., 10, 389 (2011); https://doi.org/10.1038/nmat2992
  11. M.M. El-Hammadi, A.V. Delgado, C. Melguizo, J.C. Prados and J.L. Arias, Int. J. Pharm., 516, 61 (2017); https://doi.org/10.1016/j.ijpharm.2016.11.012
  12. M. de Sousa, L.A. Visani de Luna, L.C. Fonseca, S. Giorgio and O.L. Alves, ACS Appl. Nano Mater., 1, 922 (2018); https://doi.org/10.1021/acsanm.7b00324
  13. F. Gold-Smith, A. Fernandez and K. Bishop, Nutrients, 8, 396 (2016); https://doi.org/10.3390/nu8070396
  14. S.N. Morozkina, T.H.N. Vu, Y.E. Generalova, P.P. Snetkov and M.V. Uspenskaya, Biomolecules, 11, 79 (2021); https://doi.org/10.3390/biom11010079
  15. S.S. Katiyar, E. Muntimadugu, T.A. Rafeeqi, A.J. Domb and W. Khan, Drug Deliv., 23, 2608 (2016); https://doi.org/10.3109/10717544.2015.1039667
  16. A. Debbarma, K.R.P. Roy, T.C. Lalhriatpuii and H. Lalhlenmawia, Int. J. Pharm. Sci. Res., 14, 1819 (2023); https://doi.org/10.13040/IJPSR.0975-8232.14(4).1819-27
  17. C. Gibson, J. Gibson, I. Rosenberg and S. Ott, Bioeng. Biotechnol., 8, 1 (2020); https://doi.org/10.12970/2311-1755.2020.08.01
  18. A. Garg, G. Rai, S. Lodhi, A.P. Jain and A.K. Yadav, Drug Deliv., 1, 11 (2014).
  19. F.F. Razura-Carmona, A. Pérez-Larios, N. González-Silva, M. Herrera-Martínez, L. Medina-Torres, S.G. Sáyago-Ayerdi and J.A. Sánchez-Burgos, Cancers, 11, 1965 (2019); https://doi.org/10.3390/cancers11121965
  20. I. Kazmi, F.A. Al-Abbasi, S.S. Imam, M. Afzal, M.S. Nadeem, H.N. Altayb and S. Alshehri, Polymers, 14, 1349 (2022); https://doi.org/10.3390/polym14071349
  21. A. Mukerjee and J.K. Vishwanatha, Anticancer Res., 29, 3867 (2009).
  22. D. Venkataramana and D. Krishna, J. Chromatogr., Biomed. Appl., 575, 167 (1992); https://doi.org/10.1016/0378-4347(92)80520-Z
  23. V. Dua, P. Kar, R. Sarin and V. Sharma, J. Chromatogr., Biomed. Appl., 675, 93 (1996); https://doi.org/10.1016/0378-4347(95)00357-6
  24. R.S. Douglas, A.D. Tarshis, C.H. Pletcher Jr., P.C. Nowell and J.S. Moore, J. Immunol. Methods, 188, 219 (1995); https://doi.org/10.1016/0022-1759(95)00216-2
  25. R.F. Kalejta, T. Shenk and A.J. Beavis, Cytometry, 29, 286 (1997); https://doi.org/10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8
  26. I. Vermes, C. Haanen, H. Steffens-Nakken and C. Reutellingsperger, J. Immunol. Methods, 184, 39 (1995); https://doi.org/10.1016/0022-1759(95)00072-I
  27. M. Danaei, M. Dehghankhold, S. Ataei, F.H. Davarani, R. Javanmard, A. Dokhani, S. Khorasani and M.R. Mozafari, Pharmaceutics, 10, 57, (2018); https://doi.org/10.3390/pharmaceutics10020057
  28. A. Garg, G. Rai, S. Lodhi, A.P. Jain and A.K. Yadav, Int. J. Biol. Macromol., 87, 449 (2016); https://doi.org/10.1016/j.ijbiomac.2015.11.094
Read More
Author biographies is not available.
Statistic
Read Counter : 0 Download : 0